Crizotinib for ALK-rearranged non-small cell lung cancer: a new targeted therapy for a new target.
Gandhi L, Jänne PA. Crizotinib for ALK-rearranged non-small cell lung cancer: a new targeted therapy for a new target. Clin Cancer Res. 2012 Jul 15; 18(14):3737-42.